KRM Ayurveda's shares traded at a 17% grey market premium ahead of its NSE SME listing, signaling strong investor confidence. The Rs 77 crore IPO, entirely a fresh issue, was oversubscribed 74.27 times, driven by robust demand across all investor categories.